{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:29:20Z","timestamp":1782750560522,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MURST"},{"name":"Project of National Relevence","award":["2022BPNY3E"],"award-info":[{"award-number":["2022BPNY3E"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29736-2","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T14:33:47Z","timestamp":1767105227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of plasma MicroRNA profiling as diagnostic biomarker in immune system activation and inflammation and early predictor of severity in patients with COVID-19"],"prefix":"10.1038","volume":"16","author":[{"given":"Martina","family":"Schiavello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Sanavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Dini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Cagna","family":"Vallino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Pivetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Fariselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Montrucchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"29736_CR1","doi-asserted-by":"crossref","first-page":"e019650","DOI":"10.1161\/JAHA.120.019650","volume":"10","author":"L Ortega-Paz","year":"2021","unstructured":"Ortega-Paz, L., Capodanno, D., Montalescot, G. & Angiolillo, D. J. Coronavirus disease 2019-Associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management. J. Am. Heart Assoc. 10, e019650 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"29736_CR2","unstructured":"COVID-19 deaths | WHO COVID-19 dashboard. datadot https:\/\/data.who.int\/dashboards\/covid19\/cases"},{"key":"29736_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","volume":"18","author":"SX Gu","year":"2021","unstructured":"Gu, S. X. et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 18, 194\u2013209 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"29736_CR4","doi-asserted-by":"crossref","first-page":"104305","DOI":"10.1016\/j.ebiom.2022.104305","volume":"85","author":"E Lupia","year":"2022","unstructured":"Lupia, E. et al. Thrombopoietin participates in platelet activation in COVID-19 patients. EBioMedicine 85, 104305 (2022).","journal-title":"EBioMedicine"},{"key":"29736_CR5","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3390\/ijms24031920","volume":"24","author":"M Schiavello","year":"2023","unstructured":"Schiavello, M. et al. Extracellular vesicles: new players in the mechanisms of Sepsis- and COVID-19-Related thromboinflammation. Int. J. Mol. Sci. 24, 1920 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29736_CR6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","volume":"24","author":"T Iba","year":"2020","unstructured":"Iba, T. et al. The unique characteristics of COVID-19 coagulopathy. Crit. Care. 24, 360 (2020).","journal-title":"Crit. Care"},{"key":"29736_CR7","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli, G. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323, 1574\u20131581 (2020).","journal-title":"JAMA"},{"key":"29736_CR8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"G Grasselli","year":"2020","unstructured":"Grasselli, G. et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern. Med. 180, 1345\u20131355 (2020).","journal-title":"JAMA Intern. Med."},{"key":"29736_CR9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"29736_CR10","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1038\/s41467-021-24482-1","volume":"12","author":"P Wu","year":"2021","unstructured":"Wu, P. et al. The trans-omics landscape of COVID-19. Nat. Commun. 12, 4543 (2021).","journal-title":"Nat. Commun."},{"key":"29736_CR11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman, R. C., Farh, K. K. H., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of MicroRNAs. Genome Res. 19, 92\u2013105 (2009).","journal-title":"Genome Res."},{"key":"29736_CR12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/genes14071375","volume":"14","author":"A Chakrabortty","year":"2023","unstructured":"Chakrabortty, A., Patton, D. J., Smith, B. F. & Agarwal, P. MiRNAs: potential as biomarkers and therapeutic targets for cancer. Genes (Basel). 14, 1375 (2023).","journal-title":"Genes (Basel)"},{"key":"29736_CR13","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/aps.2018.30","volume":"39","author":"S Zhou","year":"2018","unstructured":"Zhou, S. et al. MiRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol. Sin. 39, 1073\u20131084 (2018).","journal-title":"Acta Pharmacol. Sin"},{"key":"29736_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10458-x","author":"R Das","year":"2023","unstructured":"Das, R., Sinnarasan, V. S. P., Paul, D. & Venkatesan, A. A. Machine learning approach to identify potential miRNA-Gene regulatory network contributing to the pathogenesis of SARS-CoV-2 infection. Biochem. Genet. https:\/\/doi.org\/10.1007\/s10528-023-10458-x (2023).","journal-title":"Biochem. Genet."},{"key":"29736_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s10020-022-00527-z","volume":"28","author":"A Formosa","year":"2022","unstructured":"Formosa, A. & Turgeon, P. Dos Santos, C. C. Role of MiRNA dysregulation in sepsis. Mol. Med. 28, 99 (2022).","journal-title":"Mol. Med."},{"key":"29736_CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","volume":"30","author":"MA Mori","year":"2019","unstructured":"Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brand\u00e3o, B. B. & Kahn, C. R. Extracellular mirnas: from biomarkers to mediators of physiology and disease. Cell. Metab. 30, 656\u2013673 (2019).","journal-title":"Cell. Metab."},{"key":"29736_CR17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/microorganisms12030440","volume":"12","author":"S Franco","year":"2024","unstructured":"Franco, S. et al. Altered plasma MicroRNA signature in hospitalized COVID-19 patients requiring oxygen support. Microorganisms 12, 440 (2024).","journal-title":"Microorganisms"},{"key":"29736_CR18","doi-asserted-by":"crossref","first-page":"e1009759","DOI":"10.1371\/journal.ppat.1009759","volume":"17","author":"RJ Farr","year":"2021","unstructured":"Farr, R. J. et al. Altered MicroRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 17, e1009759 (2021).","journal-title":"PLoS Pathog"},{"key":"29736_CR19","doi-asserted-by":"crossref","first-page":"104309","DOI":"10.1016\/j.isci.2022.104309","volume":"25","author":"Q Zeng","year":"2022","unstructured":"Zeng, Q. et al. Distinct MiRNAs associated with various clinical presentations of SARS-CoV-2 infection. iScience 25, 104309 (2022).","journal-title":"iScience"},{"key":"29736_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cvr\/cvab338","volume":"118","author":"C Gutmann","year":"2022","unstructured":"Gutmann, C. et al. Association of cardiometabolic MicroRNAs with COVID-19 severity and mortality. Cardiovasc. Res. 118, 461\u2013474 (2022).","journal-title":"Cardiovasc. Res."},{"key":"29736_CR21","doi-asserted-by":"crossref","first-page":"20048","DOI":"10.1038\/s41598-022-23922-2","volume":"12","author":"A Mad\u00e8","year":"2022","unstructured":"Mad\u00e8, A. et al. Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality. Sci. Rep. 12, 20048 (2022).","journal-title":"Sci. Rep."},{"key":"29736_CR22","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S. et al. Circulating MicroRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U S A. 105, 10513\u201310518 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"29736_CR23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.12236","volume":"18","author":"L Moldovan","year":"2014","unstructured":"Moldovan, L. et al. Methodological challenges in utilizing MiRNAs as Circulating biomarkers. J. Cell. Mol. Med. 18, 371\u2013390 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"29736_CR24","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru, Y. et al. The MultiMiR R package and database: integration of microRNA\u2013target interactions along with their disease and drug associations. Nucleic Acids Res. 42, e133 (2014).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR25","doi-asserted-by":"crossref","first-page":"D105","DOI":"10.1093\/nar\/gkn851","volume":"37","author":"F Xiao","year":"2009","unstructured":"Xiao, F. et al. MiRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 37, D105\u2013110 (2009).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR26","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2021","unstructured":"Huang, H. Y. et al. MiRTarBase update 2022: an informative resource for experimentally validated miRNA\u2013target interactions. Nucleic Acids Res. 50, D222\u2013D230 (2021).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR27","doi-asserted-by":"publisher","unstructured":"Skoufos, G. et al. TarBase-v9.0 extends experimentally supported miRNA-gene interactions to cell-types and virally encoded MiRNAs. Nucleic Acids Res. gkad1071 https:\/\/doi.org\/10.1093\/nar\/gkad1071 (2023).","DOI":"10.1093\/nar\/gkad1071"},{"key":"29736_CR28","doi-asserted-by":"crossref","first-page":"W145","DOI":"10.1093\/nar\/gkr294","volume":"39","author":"M Maragkakis","year":"2011","unstructured":"Maragkakis, M. et al. DIANA-microT web server upgrade supports fly and worm MiRNA target prediction and bibliographic MiRNA to disease association. Nucleic Acids Res. 39, W145\u2013W148 (2011).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2105-8-69","volume":"8","author":"D Gaidatzis","year":"2007","unstructured":"Gaidatzis, D., van Nimwegen, E., Hausser, J. & Zavolan, M. Inference of MiRNA targets using evolutionary conservation and pathway analysis. BMC Bioinform. 8, 69 (2007).","journal-title":"BMC Bioinform."},{"key":"29736_CR30","doi-asserted-by":"crossref","first-page":"D154","DOI":"10.1093\/nar\/gkm952","volume":"36","author":"S Griffiths-Jones","year":"2008","unstructured":"Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. MiRBase: tools for MicroRNA genomics. Nucleic Acids Res. 36, D154\u2013158 (2008).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR31","doi-asserted-by":"crossref","first-page":"D149","DOI":"10.1093\/nar\/gkm995","volume":"36","author":"D Betel","year":"2008","unstructured":"Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149\u2013153 (2008).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR32","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 48, D127\u2013D131 (2020).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR33","doi-asserted-by":"crossref","first-page":"D180","DOI":"10.1093\/nar\/gkr1007","volume":"40","author":"G Anders","year":"2012","unstructured":"Anders, G. et al. DoRiNA: a database of RNA interactions in post-transcriptional regulation. Nucleic Acids Res. 40, D180\u2013D186 (2012).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR34","doi-asserted-by":"crossref","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary, S. E. et al. The biochemical basis of MicroRNA targeting efficacy. Science 366, eaav1741 (2019).","journal-title":"Science"},{"key":"29736_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed Pairing, often flanked by Adenosines, indicates that thousands of human genes are MicroRNA targets. Cell 120, 15\u201320 (2005).","journal-title":"Cell"},{"key":"29736_CR36","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"29736_CR37","doi-asserted-by":"crossref","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","volume":"46","author":"DN Slenter","year":"2018","unstructured":"Slenter, D. N. et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 46, D661\u2013D667 (2018).","journal-title":"Nucleic Acids Res."},{"key":"29736_CR38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335 (1950).","journal-title":"Cancer"},{"key":"29736_CR39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2147\/JIR.S278335","volume":"13","author":"T Shibabaw","year":"2020","unstructured":"Shibabaw, T. & Inflammatory Cytokine IL-17A signaling pathway in patients present with COVID-19 and current treatment strategy. J. Inflamm. Res. 13, 673\u2013680 (2020).","journal-title":"J. Inflamm. Res."},{"key":"29736_CR40","doi-asserted-by":"crossref","first-page":"832394","DOI":"10.3389\/fimmu.2022.832394","volume":"13","author":"RJ Hsu","year":"2022","unstructured":"Hsu, R. J. et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front. Immunol. 13, 832394 (2022).","journal-title":"Front. Immunol."},{"key":"29736_CR41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.immuni.2020.06.024","volume":"53","author":"C Schulthei\u00df","year":"2020","unstructured":"Schulthei\u00df, C. et al. Next-Generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity 53, 442\u2013455e4 (2020).","journal-title":"Immunity"},{"key":"29736_CR42","doi-asserted-by":"crossref","first-page":"888248","DOI":"10.3389\/fimmu.2022.888248","volume":"13","author":"C Di Vito","year":"2022","unstructured":"Di Vito, C. et al. Natural killer cells in SARS-CoV-2 infection: pathophysiology and therapeutic implications. Front. Immunol. 13, 888248 (2022).","journal-title":"Front. Immunol."},{"key":"29736_CR43","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-024-48055-0","volume":"15","author":"B Qiu","year":"2024","unstructured":"Qiu, B. et al. Fatal COVID-19 pulmonary disease involves ferroptosis. Nat. Commun. 15, 3816 (2024).","journal-title":"Nat. Commun."},{"key":"29736_CR44","doi-asserted-by":"crossref","unstructured":"Breikaa, R. M. & Lilly, B. The Notch pathway: A link between COVID-19 pathophysiology and its cardiovascular complications. Front Cardiovasc. Med. 8, 681948 (2021).","DOI":"10.3389\/fcvm.2021.681948"},{"key":"29736_CR45","unstructured":"Increased mTOR Signaling. and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection. https:\/\/www.mdpi.com\/1467-3045\/45\/1\/23"},{"key":"29736_CR46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","volume":"6","author":"M Tian","year":"2021","unstructured":"Tian, M. et al. HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal. Transduct. Target. Ther. 6, 308 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"29736_CR47","doi-asserted-by":"crossref","first-page":"107806","DOI":"10.1016\/j.intimp.2021.107806","volume":"98","author":"D Sellegounder","year":"2021","unstructured":"Sellegounder, D., Zafari, P., Rajabinejad, M., Taghadosi, M. & Kapahi, P. Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis. Int. Immunopharmacol. 98, 107806 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"29736_CR48","first-page":"104","volume":"11","author":"D Saleh","year":"2024","unstructured":"Saleh, D. et al. The clinical impact of SARS-CoV-2 on hypertrophic cardiomyopathy. J. Cardiovasc. Dev. Dis. 11, 104 (2024).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"29736_CR49","doi-asserted-by":"crossref","first-page":"687783","DOI":"10.3389\/fcvm.2021.687783","volume":"8","author":"S Raghavan","year":"2021","unstructured":"Raghavan, S., Kenchappa, D. B. & Leo, M. D. SARS-CoV-2 Spike protein induces degradation of junctional proteins that maintain endothelial barrier integrity. Front. Cardiovasc. Med. 8, 687783 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"29736_CR50","doi-asserted-by":"crossref","first-page":"611004","DOI":"10.3389\/fimmu.2020.611004","volume":"11","author":"VA Sosa-Hern\u00e1ndez","year":"2020","unstructured":"Sosa-Hern\u00e1ndez, V. A. et al. B cell subsets as Severity-Associated signatures in COVID-19 patients. Front. Immunol. 11, 611004 (2020).","journal-title":"Front. Immunol."},{"key":"29736_CR51","doi-asserted-by":"crossref","first-page":"948770","DOI":"10.3389\/fmicb.2022.948770","volume":"13","author":"J Dai","year":"2022","unstructured":"Dai, J. et al. Toll-Like receptor signaling in severe acute respiratory syndrome coronavirus 2-Induced innate immune responses and the potential application value of Toll-Like receptor immunomodulators in patients with coronavirus disease 2019. Front. Microbiol. 13, 948770 (2022).","journal-title":"Front. Microbiol."},{"key":"29736_CR52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/biomedicines9050556","volume":"9","author":"D Barh","year":"2021","unstructured":"Barh, D. et al. Predicting COVID-19\u2014Comorbidity pathway Crosstalk-Based targets and drugs: towards personalized COVID-19 management. Biomedicines 9, 556 (2021).","journal-title":"Biomedicines"},{"key":"29736_CR53","doi-asserted-by":"crossref","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 5, e138999 (2020).","DOI":"10.1172\/jci.insight.138999"},{"key":"29736_CR54","doi-asserted-by":"crossref","first-page":"1493643","DOI":"10.3389\/fimmu.2024.1493643","volume":"15","author":"E Galliera","year":"2024","unstructured":"Galliera, E. et al. Effects of COVID-19 on bone fragility: a new perspective from osteoimmunological biomarkers. Front. Immunol. 15, 1493643 (2024).","journal-title":"Front. Immunol."},{"key":"29736_CR55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017\u20131032 (2020).","journal-title":"Nat. Med."},{"key":"29736_CR56","doi-asserted-by":"crossref","unstructured":"Vivaldi, G. et al. Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study. eClinicalMedicine 65, (2023).","DOI":"10.1016\/j.eclinm.2023.102251"},{"key":"29736_CR57","doi-asserted-by":"crossref","first-page":"e23590","DOI":"10.1002\/jcla.23590","volume":"34","author":"C Li","year":"2020","unstructured":"Li, C., Hu, X., Li, L. & Li, J. H. Differential MicroRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal. 34, e23590 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"29736_CR58","doi-asserted-by":"crossref","first-page":"21656","DOI":"10.1038\/s41598-023-48227-w","volume":"13","author":"L Gao","year":"2023","unstructured":"Gao, L. et al. Circulating MiRNA profiles in COVID-19 patients and meta-analysis: implications for disease progression and prognosis. Sci. Rep. 13, 21656 (2023).","journal-title":"Sci. Rep."},{"key":"29736_CR59","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ejhf.2096","volume":"23","author":"A Garg","year":"2021","unstructured":"Garg, A. et al. Circulating cardiovascular MicroRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 23, 468\u2013475 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"29736_CR60","doi-asserted-by":"crossref","first-page":"e1003291","DOI":"10.1371\/journal.pgen.1003291","volume":"9","author":"CL Lino Cardenas","year":"2013","unstructured":"Lino Cardenas, C. L. et al. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 9, e1003291 (2013).","journal-title":"PLoS Genet."},{"key":"29736_CR61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.trsl.2021.05.004","volume":"236","author":"D de GONZALO-CALVO","year":"2021","unstructured":"de GONZALO-CALVO, D. et al. Circulating MicroRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl Res. 236, 147\u2013159 (2021).","journal-title":"Transl Res."},{"key":"29736_CR62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12931-023-02413-6","volume":"24","author":"J Guiot","year":"2023","unstructured":"Guiot, J. et al. Systematic review of overlapping MicroRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respir. Res. 24, 112 (2023).","journal-title":"Respir. Res."},{"key":"29736_CR63","doi-asserted-by":"crossref","first-page":"e0265670","DOI":"10.1371\/journal.pone.0265670","volume":"17","author":"RJ Farr","year":"2022","unstructured":"Farr, R. J. et al. Detection of SARS-CoV-2 infection by MicroRNA profiling of the upper respiratory tract. PLOS ONE. 17, e0265670 (2022).","journal-title":"PLOS ONE"},{"key":"29736_CR64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cpt.2023.09.001","volume":"2","author":"J Shen","year":"2024","unstructured":"Shen, J. et al. Current and future perspectives on the regulation and functions of miR-545 in cancer development. Cancer Pathog Ther. 2, 142\u2013154 (2024).","journal-title":"Cancer Pathog Ther."},{"key":"29736_CR65","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/biom11071032","volume":"11","author":"MC Kuo","year":"2021","unstructured":"Kuo, M. C., Chang, W. A., Wu, L. Y., Tsai, Y. C. & Hsu, Y. L. Hypoxia-Induced epithelial-to-Mesenchymal transition in proximal tubular epithelial cells through miR-545-3p-TNFSF10. Biomolecules 11, 1032 (2021).","journal-title":"Biomolecules"},{"key":"29736_CR66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41598-019-57108-0","volume":"10","author":"W Bertrams","year":"2020","unstructured":"Bertrams, W. et al. Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation. Sci. Rep. 10, 241 (2020).","journal-title":"Sci. Rep."},{"key":"29736_CR67","doi-asserted-by":"crossref","unstructured":"Molinero, M. et al. Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection. Frontiers Immunology. 13, 942443 (2022).","DOI":"10.3389\/fimmu.2022.942443"},{"key":"29736_CR68","doi-asserted-by":"crossref","first-page":"106848","DOI":"10.1016\/j.intimp.2020.106848","volume":"88","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. MiRNA-133a aggravates inflammatory responses in sepsis by targeting SIRT1. Int. Immunopharmacol. 88, 106848 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"29736_CR69","doi-asserted-by":"crossref","unstructured":"Xu, P. et al. Serum miR-133 as a potential biomarker in acute cerebral infarction patients. Clin Lab. 66, 10 (2020).","DOI":"10.7754\/Clin.Lab.2019.190933"},{"key":"29736_CR70","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","volume":"55","author":"T Kim","year":"2023","unstructured":"Kim, T. & Croce, C. M. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp. Mol. Med. 55, 1314\u20131321 (2023).","journal-title":"Exp. Mol. Med."},{"key":"29736_CR71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/22221751.2022.2038021","volume":"11","author":"A Fern\u00e1ndez-Pato","year":"2022","unstructured":"Fern\u00e1ndez-Pato, A. et al. Plasma MiRNA profile at COVID-19 onset predicts severity status and mortality. Emerg. Microbes Infections. 11, 676\u2013688 (2022).","journal-title":"Emerg. Microbes Infections"},{"key":"29736_CR72","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41401-018-0041-7","volume":"40","author":"Q Tang","year":"2019","unstructured":"Tang, Q. et al. Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy. Acta Pharmacol. Sin. 40, 208\u2013215 (2019).","journal-title":"Acta Pharmacol. Sin"},{"key":"29736_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4940","volume":"47","author":"M Trovato","year":"2021","unstructured":"Trovato, M. et al. Interleukin\u20136 signalling as a valuable cornerstone for molecular medicine (Review). Int. J. Mol. Med. 47, 1\u20139 (2021).","journal-title":"Int. J. Mol. Med."},{"key":"29736_CR74","first-page":"48","volume":"10","author":"AM Timofeeva","year":"2024","unstructured":"Timofeeva, A. M., Nikitin, A. O. & Nevinsky, G. A. Circulating MiRNAs in the plasma of Post-COVID-19 patients with typical recovery and those with Long-COVID symptoms: regulation of immune Response-Associated pathways. Noncoding RNA. 10, 48 (2024).","journal-title":"Noncoding RNA"},{"key":"29736_CR75","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1038\/s41598-023-30474-6","volume":"13","author":"HA Mohamed","year":"2023","unstructured":"Mohamed, H. A. et al. MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression. Sci. Rep. 13, 3531 (2023).","journal-title":"Sci. Rep."},{"key":"29736_CR76","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1253\/circj.CJ-19-1181","volume":"84","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Circulating MicroRNA-423-3p improves the prediction of coronary artery disease in a general Population - Six-Year Follow-up results from the China-Cardiovascular disease study. Circ. J. 84, 1155\u20131162 (2020).","journal-title":"Circ. J."},{"key":"29736_CR77","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/22221751.2019.1590129","volume":"8","author":"H Tu","year":"2019","unstructured":"Tu, H. et al. Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion. Emerg. Microbes Infections. 8, 448\u2013460 (2019).","journal-title":"Emerg. Microbes Infections"},{"key":"29736_CR78","doi-asserted-by":"crossref","unstructured":"Shen, Y., Yu, J., Jing, Y. & Zhang, J. MiR-106a aggravates sepsis-induced acute kidney injury by targeting THBS2 in mice model 1. Acta Cir. Bras. 34, e201900602 (2019).","DOI":"10.1590\/s0102-865020190060000002"},{"key":"29736_CR79","first-page":"249","volume":"19","author":"Y Lin","year":"2019","unstructured":"Lin, Y. et al. Expression patterns and prognostic value of miR-210, miR-494, and miR-205 in middle-aged and old patients with sepsis-induced acute kidney injury. Bosn J. Basic. Med. Sci. 19, 249\u2013256 (2019).","journal-title":"Bosn J. Basic. Med. Sci."},{"key":"29736_CR80","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1038\/s41598-022-10738-3","volume":"12","author":"N Garcia-Giralt","year":"2022","unstructured":"Garcia-Giralt, N. et al. Circulating MicroRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection. Sci. Rep. 12, 6929 (2022).","journal-title":"Sci. Rep."},{"key":"29736_CR81","doi-asserted-by":"crossref","first-page":"509","DOI":"10.14336\/AD.2020.0428","volume":"11","author":"S Fulzele","year":"2020","unstructured":"Fulzele, S. et al. COVID-19 virulence in aged patients might be impacted by the host cellular MicroRNAs Abundance\/Profile. Aging Dis. 11, 509\u2013522 (2020).","journal-title":"Aging Dis."},{"key":"29736_CR82","doi-asserted-by":"crossref","first-page":"815651","DOI":"10.3389\/fimmu.2021.815651","volume":"12","author":"P Mart\u00ednez-Fleta","year":"2021","unstructured":"Mart\u00ednez-Fleta, P. et al. A differential signature of Circulating MiRNAs and cytokines between COVID-19 and Community-Acquired pneumonia uncovers novel physiopathological mechanisms of COVID-19. Front. Immunol. 12, 815651 (2021).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29736-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29736-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29736-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:42:11Z","timestamp":1767624131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29736-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29736"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29736-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted in compliance with the World Medical Association Declaration of Helsinki. All patients provided oral informed consent (as specifically authorized by the Ethical Committee during the COVID-19 pandemic due to infection risk management in ER) for the participation to the study, and all data were immediately de-identified. The study was approved by the Institutional Ethical Committee (A.O.U. Citt\u00e0 della Salute e della Scienza di Torino \u2013 A.O. Ordine Mauriziano \u2013 A.S.L. Citt\u00e0 di Torino) (number of approval CS2\/139).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}